Save millions of lives by enabling early diagnosis of complex diseases.
About Scailyte
We are an innovative Swiss-based company developing artificial intelligence (AI) technology for clinical research and diagnostics. We are offering a unique solution for the discovery of novel biomarkers for ultra-sensitive and early detection of complex diseases.
Latest news
Check our latest achievements and news
Scailyte – one of the 101 innovative digital health startups
Published on: April 18, 2018
Scailyte has been marked as one of 101 innovative digital health, eHealth, mHealth startups in Switzerland by Dr. Hempel Digital Health Network.
Interview with Prof. Dr. Manfred Claassen
Published on: March 11, 2018
Prof. Dr. Manfred Claassen presenting his latest research at the ETH Zürich, the limitations and the future of single-cell technology.
DeepTech & Entrepreneurship
Event date: March 5, 2018
From fundamental research to users - meet us in Paris on 5th of March.